0001596771-21-000068.txt : 20211104
0001596771-21-000068.hdr.sgml : 20211104
20211104165738
ACCESSION NUMBER: 0001596771-21-000068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211103
FILED AS OF DATE: 20211104
DATE AS OF CHANGE: 20211104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Price Ben Gil
CENTRAL INDEX KEY: 0001417915
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 211380907
MAIL ADDRESS:
STREET 1: 8297 CHAMPIONS GATE BLVD. #444
CITY: CHAMPIONS GATE
STATE: FL
ZIP: 33896
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-11-03
0
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001417915
Price Ben Gil
C/O NEUROBO PHARMACEUTICALS, INC.
200 BERKELEY STREET, OFFICE 19TH FLOOR
BOSTON
MA
02116
0
1
0
0
CEO and President
Nonstatutory Stock Option (right to buy)
2.04
2021-11-03
4
A
0
616666
0
A
2031-11-03
Common Stock
616666
616666
D
266,666 shares subject to the option vest on the first anniversary of the vesting commencement date, November 3, 2021, and the remaining 350,000 shares subject to the option vest on the second anniversary of the vesting commencement date, subject to the Reporting Person's continuous service.
/s/ Ben Gil Price
2021-11-04